Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trial - Publikation - Autoren - KSSG Forschungsdatenbank

Publikation

Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trial

Wissenschaftlicher Artikel/Review - 16.02.2010

Cordier D, Reubi J C, Mäcke H, Müller-Brand J, Good S, Apostolidis C, Morgenstern A, Bruchertseifer F, Forrer Flavio, Merlo A

Cordier, D

Forrer, Flavio

Leiter Nuklearmedizin
Leitende(r) Arzt/Ärztin
Radiologie und Nuklearmedizin · Dept. IV

Bruchertseifer, F

Morgenstern, A

Apostolidis, C

Good, S

Müller-Brand, J

Mäcke, H

Reubi, J C

Merlo, A